February 11, 2019 / 1:23 PM / a month ago

BRIEF-Eton Pharmaceuticals Enters License Agreement For Two Branded Hospital Products

Feb 11 (Reuters) - Eton Pharmaceuticals Inc:

* ETON PHARMACEUTICALS ENTERS INTO LICENSE AGREEMENT FOR TWO BRANDED HOSPITAL PRODUCT CANDIDATES

* ETON PHARMACEUTICALS INC - ET-203 NDA EXPECTED TO BE SUBMITTED BY Q3 2019

* ETON PHARMACEUTICALS INC - ET-202 NDA WAS SUBMITTED IN DECEMBER 2018; PDUFA DATE EXPECTED TO BE IN Q4 2019

* ETON PHARMACEUTICALS - TO PAY SINTETICA $3 MILLION UPON EXECUTION OF AGREEMENTS, OBLIGATED TO PAY ADDITIONAL $750,000 UPON APPROVAL OF EACH PRODUCT

* ETON PHARMACEUTICALS - ENTERED EXCLUSIVE AGREEMENT WITH SINTETICA SA TO OBTAIN U.S. MARKETING RIGHTS TO 2 INJECTABLE PRODUCT CANDIDATES

* ETON PHARMACEUTICALS - SINTETICA TO SUPPLY PRODUCT TO CO AT DIRECT COSTS & PROFIT FROM CO’S COMMERCIAL SALES TO BE SHARED EQUALLY BY BOTH PARTIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below